Alrex

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved March 1998

Specific Treatments:

seasonal allergic conjunctivitis

Therapeutic Areas

General Information

Alrex is indicated for the treatment of seasonal allergic conjunctivitis, an inflammation of the eye usually caused by pollens. Seasonal allergic conjunctivitis produces itching, tearing, redness, and swelling in the membrane that covers the inside of the eyelid and the white part of the eye.